Non-invasive cancer detection

Issue: BCMJ, vol. 53, No. 1, January February 2011, Page 16 News

Dr Haishan Zeng, senior scientist at BCCA and one of the co-inventors of a device for early cancer detection.
Dr Haishan Zeng, senior scientist at BCCA and one of the co-inventors of a device for early cancer detection.

 

A new non-invasive cancer detection technology has been developed by cancer researchers and dermatologists at the BC Cancer Agency and the University of British Columbia. The technology is designed to assist in early detection of skin cancer and can be used by any health care professional—dermatologist, family doctor, nurse, or technician. 

The device, called the Verisante Aura series, has been in development at the BC Cancer Agency for more than 6 years and has been tested on about 1000 lesions at the Skin Care Centre at VGH. Preliminary clinical results have so far demonstrated 100% efficacy in detecting malignant mela­noma.

Using a light ray, the device measures 21 biomarkers to scan a mole or lesion to determine skin cancer in less than 2 seconds. It will help avoid unnecessary biopsies and detect more early-stage cancers that would otherwise go unnoticed. This platform technology is adaptable to other types of cancers such as lung, colon, cervical, and gastro­intestinal cancers.

Vancouver’s Verisante Technology, Inc., a medical device company, has ob­tained the rights to the device.

. Non-invasive cancer detection . BCMJ, Vol. 53, No. 1, January, February, 2011, Page(s) 16 - News.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply